flâneur

李明翰 Scott Li _

3 followers · 1 following · 314 views

on the atlas — 31

highlights — 43

  • Strategic Planning, PHC, Policy and Access
    Gmail
  • Strategic Planning, PHC, Policy and Access
    Gmail
  • Products Ltd. Strategic Planning, PHC, Policy and Access
    Gmail
  • “I’m really excited about the potential for experimentation. Expectations around what productivity looks like have been upended. I see lots of opportunity to rethink things and find out what is working and what isn’t.”
    Reasons for optimism after a difficult year | Bill Gates
  • Reasons for optimism after a difficult year 2021 was an incredibly hard year for many people, including me, but I’m hopeful that 2022 will be better.
    Reasons for optimism after a difficult year | Bill Gates
  • GP: You’ve used the phrase “institutionalized entrepreneurship” to describe what you do. That’s interesting, because for some people that combination of words is an oxymoron.
    Can Breakthrough Innovations Be Made… | Flagship Pioneering
  • Health systems are investing to expand their reach outside the hospital, with an increasing focus on the home (for example, hospital-at-home models or home-based infusions) and lower-acuity care settings (for example, ambulatory surgery and primary-care clinics).
    What payer-led managed care models may look like | McKinsey
  • Payers should consider the implications of directly competing with local providers (rather than focusing on partnerships and provider support services), focus on the willingness and ability to make acquisitions (rather than focusing on internal build and development), consider the importance of strategic control of assets (as opposed to capital-light approaches), and focus on engagement with providers (rather than direct-to-member solutions).
    What payer-led managed care models may look like | McKinsey
  • Should a good company be a good Samaritan?
    Gmail
  • https://www.hbs.edu/faculty/Pages/item.aspx?num=58942
    Facebook - Log In or Sign Up
  • One lab accident away from being a super villain
    Facebook - Log In or Sign Up
  • Mission BioCapital collects $275m for fifth fund
    Mission BioCapital collects $275m for fifth fund | Venture Capital Journal
  • Congratulations to Mammoth Biosciences on $195 million financing at $1 billion+ valuation, led by Redmile Group and Foresite Capital Mammoth Biosciences raises $195 million, vaulting Its CRISPR tech to unicorn status. The latest round of financing will supercharge the creation of transformative CRISPR products including ultra-small proteins for therapeutics and decentralized diagnostics.
    News — Pacific 8 Ventures
  • FDA OKs Gilead’s Pediatric HIV Treatment and Boehringer’s Humira Biosimilar
    FDA OKs Gilead’s Pediatric HIV Treatment and Boehringer’s Humira Biosimilar – PharmaLive
  • I'm a VC who receives tons of messages. These 6 terrible communication mistakes make me not want to respond.
    A VC Shares 6 of the Worst Communication Mistakes to Avoid
  • A primer for academic entrepreneurs on academic-industrial partnerships
    A primer for academic entrepreneurs on academic-industrial partnerships | Nature Communications
  • Partnerships between academic investigators and industry can accelerate the translation of research findings into life-saving products. The healthcare industry has witnessed heightened interest from universities in capitalizing on the discoveries made by faculty to create intellectual property, form new companies and seek investments. However, academic investigators and even Biotechnology start-ups may be unfamiliar with how industry sources and evaluates these opportunities. In this Comment, we share the approaches and principles by which a large healthcare company sources innovation and asse…
    A primer for academic entrepreneurs on academic-industrial partnerships | Nature Communications
  • How to raise capital via newsletter updates Learn why an investor newsletter is one of the most effective ways to fundraise and how to write a newsletter that converts!
    ViewSonic x Hustle Fund - Acceleration for all 2022
  • George Church, his stu­dents, and top VCs go na­tion­wide with a biotech train­ing camp
    George Church, his students, and top VCs go nationwide with a biotech training camp – Endpoints News
  • Riddhiman Das 1st degree connection1st Co-Founder & CEO at TripleBlind (Cryptographically enforced Privacy as a Service)
    Riddhiman Das | LinkedIn
  • Mayo Clinic, the renowned US healthcare company, has invested in TripleBlind, a startup developing a platform that enables companies to train models on encrypted data.
    Mayo Clinic invests in data privacy startup TripleBlind
  • RA Capital Management, LP Closes $880 Million Venture Capital Fund
    RA Capital Management, LP Closes $880 Million Venture
  • Venture capitalist Mike Speiser had a historic 2020. His firm, Sutter Hill Ventures, turned an initial investment of less than $200 million in Snowflake into a stake worth $12 billion after its IPO in September.
    How Mike Speiser and Sutter Hill are changing the rules for VC
  • Our company-building efforts are guided by our internal research division known as TechAtlas
    RA Capital | Venture
  • Deerfield works across the healthcare ecosystem, connecting people, capital, ideas, and technology in new, and often unexpected ways.
    Deerfield
  • Since 1991, the Frazier Life Sciences team has actively partnered with exceptional entrepreneurs to develop novel and impactful therapies for patients. Underlying these efforts are a set of core values that guide how we invest, advise, and operate as a firm.
    https://www.frazierhealthcare.com/life-sciences/values
  • Albert is a co-founder of the annual Dermatology Summit and Dermatology Innovation Forum
    Albert Cha | Managing Partner at Frazier Healthcare Partners
  • A surgical team at Duke University Hospital discuss their successful implant of a new-generation artificial heart in a 39-year-old patient with heart failure, the first such surgery in North America.
    Duke Surgeons First in U.S. to Implant New Generation Artificial Heart | Media Briefing - YouTube
  • These days, I head up a team of investors and scientists at Lowercarbon Capital pursuing the world’s most ambitious solutions to the climate crisis threatening all life on the planet. Across the realms of clean energy, building materials, transportation, food, reforestation, industrial chemicals, and all of the underlying logistics, Lowercarbon is funding the unfundable and showing the world that, while doing so is good for the world, it’s also just good business. In parallel with this work, Crystal and I have become prolific supporters of non-profit climate research.
    About | Chris Sacca
  • Promising explorations become prototype companies, or “ProtoCos,” and are assigned a number according to their place in the series of Flagship Labs ventures: “FL1,” “FL2,”… “FL63,” etc. Flagship Pioneering founding teams test concepts, and discontinue ProtoCos that cannot, for whatever reason, validate their science in the laboratory. We use the word "origination" to mean the conception, iteration, and launch of a new company around a distinct breakthrough. We originate eight to ten ProtoCos every year.
    Process | Flagship Pioneering
  • Flagship Labs poses farfetched hypotheses, exploring the question “What if...?” Our entrepreneurial scientists allow hypotheses to evolve through variation and selection, collaborating with external experts to test the weaknesses and strengths of new concepts. We create better and better hypotheses until we identify something that might be a breakthrough, if only it worked. We call these imaginative inquiries "explorations,” and conduct 80 to 100 a year.
    Process | Flagship Pioneering
  • I am a huge fan of the life science tools area and the impact it is having on diagnostics and ultimately devices. A lot of that comes down to having better measurements, more of them, with faster time to answer, and then lowering the cost per data point. A major part of the price drop in semiconductors is driven off the improvement in metrology, which is the measurement of all things inside the reactor, getting control of all those factors, and then allowing you to scale. The entire innovation cycle works better and faster, and that plays directly to the smaller biotechs that are venture backe…
    ARCH Venture Partners Interview - USA Pharma & Biopharma 2021
  • We’re catalyzing discoveries that prevent, detect, and cure disease.
    Home - Arch Venture Partners
  • 藥物前景全局情報 藥物銷售預測、競爭對手情報資料、市場趨勢及機會的全面分析。 早期(臨床前)研發階段新藥和新創公司資訊。 交易情報，包含交易紀錄、合約原文查詢
    台灣生醫創新生態資料庫 (biotwiidb)
  • 提供全球生醫領域新創相關資訊，包含company profiles, product pipelines, licensing opportunities, financing rounds, licensing deals, management details等等。
    台灣生醫創新生態資料庫 (biotwiidb)
  • In the document, best practices for European distribution and supply integrity management are highlighted as emerged from discussions with Alira Helth’s internal experts and industry practitioners.
    Education Hub | Alira Health
  • Prior to F-Prime, Alex was a healthcare strategy consultant with Analysis Group, where he advised biotech and pharmaceutical companies on value proposition strategy, pricing/market access, and health economics/outcomes research.
    Alex Wong | F-Prime Capital
  • All Flightradar24 data services contain flight tracking data sourced from the same technology that powers our own live webpage and mobile applications. Live flight tracking data is received primarily from both our own and volunteer hosted global ADS-B network (read more about this here),
    Data services - data tailored to your business requirements | Flightradar24
  • At CURE. — Deerfield’s innovation campus on 345 Park Avenue South — we’re transforming healthcare. Here, innovators from across the industry and around the world work shoulder to shoulder to develop treatments to eliminate deadly diseases and create new healthcare delivery models to lower cost and improve care for those in need.
    Deerfield
  • Science Based Targets initiative (SBTi),
    Reducing our Footprint: It’s Time to Get More Ambitious
  • We have one planet, with limited resources – and no alternative
    Sign Up | LinkedIn
  • science-based businesses
    Our Value | Flagship Pioneering
  • Value is at the heart of our process for company creation.
    Our Value | Flagship Pioneering